PT Diastika Biotekindo Tbk (IDX:CHEK)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
202.00
+2.00 (1.00%)
At close: Sep 15, 2025

IDX:CHEK Income Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
171,294154,792129,098117,468
Revenue Growth (YoY)
45.82%19.90%9.90%-
Cost of Revenue
103,49496,74683,14176,290
Gross Profit
67,80058,04645,95641,178
Selling, General & Admin
41,97538,16733,56327,836
Other Operating Expenses
267.75515.71277.27120.65
Operating Expenses
42,24338,68333,84027,957
Operating Income
25,55719,36312,11713,221
Interest Expense
--258.55-32.73-0.15
Interest & Investment Income
451.22183.57260.67331.56
Currency Exchange Gain (Loss)
261.69261.69-514.78626.84
Other Non Operating Income (Expenses)
-268.98-268.985,542-47.41
EBT Excluding Unusual Items
26,00119,28117,37114,132
Gain (Loss) on Sale of Assets
5.595.59169.22,627
Pretax Income
26,00619,28717,54016,759
Income Tax Expense
4,1124,1123,9503,723
Net Income
21,89415,17513,59113,035
Net Income to Common
21,89415,17513,59113,035
Net Income Growth
67.96%11.65%4.26%-
Shares Outstanding (Basic)
2,5122,5122,5122,512
Shares Outstanding (Diluted)
2,5122,5122,5122,512
EPS (Basic)
8.726.045.415.19
EPS (Diluted)
8.726.045.415.19
EPS Growth
67.96%11.65%4.26%-
Free Cash Flow
6,521-1,9343,330534.23
Free Cash Flow Per Share
2.60-0.771.330.21
Gross Margin
39.58%37.50%35.60%35.05%
Operating Margin
14.92%12.51%9.39%11.25%
Profit Margin
12.78%9.80%10.53%11.10%
Free Cash Flow Margin
3.81%-1.25%2.58%0.46%
EBITDA
34,73926,97217,46018,775
EBITDA Margin
20.28%17.42%13.53%15.98%
D&A For EBITDA
9,1827,6095,3435,553
EBIT
25,55719,36312,11713,221
EBIT Margin
14.92%12.51%9.39%11.25%
Effective Tax Rate
15.81%21.32%22.52%22.22%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.